Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol in Gynecological Surgery
NCT06990763Not yet recruiting
- Sponsor
- The Second Hospital of Shanxi Medical University
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Randomised trial of remimazolam in gynecological disorders (2 arms), sponsored by The Second Hospital of Shanxi Medical University. Primary endpoints: Serum Nociceptin/Orphanin FQ Level, Serum Interleukin-6 Level and 1 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
gynecological disorders
Beyond the preview
Go deeper on NCT06990763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06990763.